Dear Mark,
I tried a couple of weeks ago to get you to issue the biggest convertible bond ever to help you buy companies. My editors got a little upset when I jokingly suggested you buy my new company at the kind of valuation you��e paying for hot new technologies, many of which are in no foreseeable danger of making money. They said it distracted too much from the point of the article, which was that Facebook should be the company to do a landmark convertible.
So I wrote another piece talking about how you and Ken Griffin, both Harvard guys, should get together and talk about how Facebook should do the biggest convertible bond ever. Ken, after all, became a billionaire through his convertible prowess. You might say he�� the Mark Zuckerberg of convertibles. Or you��e the Ken Griffin of the Internet. Or something.
Here�� the thing, Mark: it�� clear that you��e going to be doing a lot more shopping. And there are really only two things you can use for currency: cash and Facebook stock. You used both of them, mostly your stock, to pay for your newest acquisition, Oculus.
Top 5 Building Product Companies To Own In Right Now: MEDIWARE Information Systems Inc.(MEDW)
Mediware Information Systems, Inc., together with its subsidiaries, engages in the design, development, and marketing of software solutions targeting specific processes within healthcare institutions. The company offers software systems consisting of company's proprietary application software, and third-party licensed software and hardware. It licenses, implements, and supports clinical and performance management, blood donor, and blood and biologic management products in the United States; and medication management solutions in the United States, the United Kingdom, Ireland, and South Africa. The company?s blood and biologics management solutions include HCLL Transfusion and HCLL Donor, which address blood donor recruitment, blood processing, and transfusion activities for hospitals and medical centers; BloodSafe suite of hardware and software that enable healthcare facilities to store, monitor, distribute, and track blood products; LifeTrak software for blood centers; a nd BiologiCare, a bone, tissue, and cellular product tracking software. Its medication management products comprise WORx, a pharmacy information system to manage inpatient and outpatient pharmacy operations; MediCOE, a physician order entry module; MediMAR, a nurse point-of-care administration and bedside documentation module; MediREC, which assists in achieving compliance with a Joint Commission mandate; and pharmacy management and electronic prescribing systems. The company?s performance management products include InSight software that tracks performance metrics to assist healthcare managers to manage performance. It also provides software installation and maintenance services, as well as billing and collection services to home infusion and home/durable medical equipment markets. The company markets its products primarily through its direct sales force. Mediware Information Systems, Inc. was founded in 1970 and is headquartered in Lenexa, Kansas.
Advisors' Opinion:- [By CRWE]
Mediware Information Systems, Inc. (Nasdaq:MEDW) plans to acquire the assets of Indianapolis-based Strategic Healthcare Group LLC (SHG), a leading provider of blood management consulting, education and informatics solutions.
Hot Tech Companies For 2014: China Mobile Games and Entertainment Group Ltd (CMGE)
China Mobile Games and Entertainment Group Limited, incorporated on January 20, 2011, is a holding company. The Company is engaged in the development, operation and sale of feature phone and smartphone games, as well as the provision of handset design products and services. The Company operates in three segments: feature phone games, smartphone games and handset design. As of December 31, 2011, it was a subsidiary of VODone Limited.
CMGEconducts its primary business operations through its subsidiaries and a variable interest entity (VIE). Kangri Yingxiong Zhuan is a single-player smartphone game, which was launched during the year ended December 31, 2011.Paopao Xiyou, YY Three Kingdoms, Thumb Monopoly and Creation Song are its smartphone mobile social games. Xiao'ao Jianghu is its internally-developed feature phone mobile social game. The Company has a diversified portfolio of games for feature phones and smartphones. As of March 31, 2012, the Company�� portfolio included 450 mobile games, of which 130 of its 136 feature phone games were developed in-house; it licensed 302 of its 314 smartphone games from third parties and it developed its smartphone mobile social games in-house.
On February 14, 2012, the Company established four wholly owned subsidiaries, which included HYD Holding Limited, OWX Group Limited, OWX Development Limited and 3GUU Holding Limited. On March 23, 2012, CMGE transferred all of the interests in Beauty Wave Limited (Beauty Wave) and China Wave Group Limited (China Wave) to HYD Holding Limited; transferred all of the interests in OWX Hong Kong Limited (OWX HK) to OWX Development Limited, and transferred all of the interest in 3GUU Mobile Entertainment Industrial Co. Ltd. (3GUU BVI) to 3GUU Holding Limited.
The Company generates feature phone games revenues principally from the sale of in-game features of mobile phone games on feature phones. The Company generates smartphone game revenues from the sale of in-game premium features of mobile ! social games that it develops in-house, as well as from the sale of single-player games on smartphones that it develops in-house and license or acquire. CMGE operates mobile social games and single-player games under a free-to-play model and a subscription-based model, respectively. The Company contracts with third-party payment platforms for billing, collection and transmission services offered to mobile phone game players who have purchased game points. It also contracts with mobile application and software Websites to distribute its mobile social games by providing platforms for mobile phone game players to download such games.
CMGE generates handset design revenues from the provision of handset design solutions to mobile phone manufacturers and mobile phone content providers. Handset design solutions include operating system software and hardware design with one-year post-contract customer support (PCS) service; printed circuit board with operating system software and optional assembly service, and mobile phone contents installation service. Operating system software and hardware designs with PCS services are provided to mobile phone manufacturers for either a fixed fee or a variable fee based on the units of production by the mobile phone manufacturers at a prescribed unit price. Printed circuit boards with operating system software are sold to mobile phone manufacturers for a fixed unit price. Mobile phone contents installation services are rendered to mobile phone content providers for a prescribed percentage of the mobile phone content providers' net profits.
Advisors' Opinion:- [By Monica Gerson]
China Mobile Games and Entertainment Group (NASDAQ: CMGE) is projected to report its Q2 earnings at $0.21 per share on revenue of $43.60 million.
Rediff.com India (NASDAQ: REDF) is estimated to report its Q1 earnings.
- [By Laura Brodbeck]
Monday
Earnings Releases Expected: Urban Outfitters (NASDAQ: URBN), China Mobile Games & Entertainment (NASDAQ: CMGE) Economic Releases Expected: Hong Kong unemployment rate, New Zealand’s PPITuesday
Hot Tech Companies For 2014: Compucon Computer Applications SA (COMP)
Compucon Computer Applications SA is a Greek company engaged mainly in the information technology sector. The Company's activities include the manufacture and trade of electronics and software for the embroidery, telematics, laser, Web solutions and medical fields. In the embroidery field it offers album presentation or embroidery designs, lettering with a variety of fonts, frames and specialized features, and realistic three-dimensional views of embroidery designs. The Company also produces laser cutting and engraving devices for the embroidery sector. The range of telematics applications includes automotive positioning systems, fleet management and navigation systems. Its Web solutions offering includes the SiteCosmos, which is an integrated tool for on-line content management and Website design for small and medium enterprises, while the medical applications target the management of patient-oriented information, diet schedules, word processing, prescriptions and other services. Advisors' Opinion:- [By Benjamin Pimentel]
Shares of Twitter (TWTR) �were also up 4.4% to close at $60.01. Apple Inc. (AAPL) � gained 1% to close at $549.02, giving the Nasdaq Composite Index (COMP) �a lift. The benchmark rose 1.2% to close at 4,105 on Friday, and ended the week with a 2.6% gain. Apple also posted its first stock gain in four days.
Hot Tech Companies For 2014: Actelion Ltd (ATLN.VX)
Actelion Ltd is a Swiss biopharmaceutical holding company that focuses on the discovery, development and commercialization of small molecule drugs. The Company has four approved drugs on the market: Tracleer, an oral dual endothelin receptor antagonist; Veletri, a prostanoid vasodilator; Ventavis, an inhaled formulation of iloprost, and Zavesca, an oral treatment for type 1 Gaucher disease. Furthermore, the Company has a number of compounds various stages of development. The Company operates through a number of worldwide subsidiaries, including Actelion Registration Ltd, which holds marketing authorizations for products marketed in the European Union; Actelion Clinical Research, Inc, engaged in clinical development on behalf of the Company's group; Actelion Re SA, providing insurance solutions for the Company's group and Actelion US Holding Company, engaged in the holding activities of the Company's United States-based units. In September 2013, it acquired Ceptaris Therapeutics, Inc. Advisors' Opinion:- [By Victor Selva]
Forest Laboratories has a current ratio of 2.69% which is higher than the ones registered by Endo International Plc (ENDP), Valeant Pharmaceuticals International (VRX) and Cubist Pharmaceuticals Inc. (CBST). For investors looking for a higher ROE, Allergan Inc. (AGN) and Actelion Ltd. (ATLN.VX) are good options.
Hot Tech Companies For 2014: Bazaarvoice Inc (BV)
Bazaarvoice, Inc., incorporated on May 25, 2005, connects businesses together to amplify the authentic voices of people where they shop. The Company�� solutions, which are primarily provided through Software as a Service (SaaS) platform, enable clients to capture and display online word of mouth about specific products and services, channel content into all the places where it will influence a purchase both within and outside its network, which it refers to as syndication, and use business insights so they can act on what consumers want.
Bazaarvoice Conversations Platform
The Company�� Conversations platform provides capabilities to capture, manage and display online word of mouth. Consumers interact with its solutions as they view or author consumer reviews, questions, photos, videos, long-format narratives and other forms of consumer-generated content. Content that is displayed by its Conversations platform is styled to match its clients��brand, preserving important branding elements of its clients��businesses. Content collected and managed by its Conversations platform is used by its clients in a range of applications, including their online Websites, mobile-optimized Websites, mobile applications, social networks, in-store kiosks, physical in-store displays, printed flyers, email and other forms of online and offline media. The Company�� Conversations platform allows clients to capture, manage and display consumer reviews about their products and services on their Websites and mobile-optimized Websites; allows clients to facilitate question and answer conversations between consumers, or between consumers and brand representatives, on their Websites; allows clients to collect consumer testimonials about their products and services and display these stories on their Websites; enables consumers to read or write reviews, product questions, product answers, or stories on its clients��pages on social networking Websites and easily share this content with the peopl! e they influence the most-their social network friends or followers, and provides third-party developers with tools to build products or extend its platform on behalf of its clients, which enables the Company to expand the use of its platform by leveraging applications built by third-party developers.
Bazaarvoice Connections Solutions
The Company�� Conversations clients are connected through its SaaS platform to form a network. The Company offers network syndication and brand engagement solutions to facilitate the sharing of online word of mouth among its clients and to enable brands to directly interact with consumers on its retail clients��Websites. BrandVoice enables brands to enter into distribution relationships allowing them to display review content from their brand Websites on retail Websites within its network, which it refers to as syndication. BrandAnswers enables brands to interact directly with consumers on retail websites within its network to answer questions and provide suggestions on alternative products that may better meet that consumer�� needs. Brand Response enables brands to interact with consumers by responding to reviews posted on retail Websites within its network.
Bazaarvoice Analytics Solutions
The Company�� Conversations platform includes its Intelligence solution, which is it enhanced analytics solution, and a Workbench Analytics solution, which provides analytics and self-service administration tools. Intelligence allows clients to derive sophisticated market, consumer and product insights in a timely manner from the underlying data it collects on their behalf through its platform. Workbench Analytics provides basic analytics capabilities that allow its clients to generate reports highlighting simple ratings trends, text analysis and product and service issue identification.
Bazaarvoice Media
The Company�� Bazaarvoice Media sells advertising on behalf of retailers, brands and agencie! s, and pr! ovides capabilities that incorporate consumers��authentic opinions in advertising campaigns, creating advertisements that are trusted, relevant and targeted. Bazaarvoice Media sells advertising on retail Websites, utilizing its relationships and knowledge of the intricacies of the retail environment. It develops custom programs for brands to reach consumers while they are in the shopping environment, while also selling to non-retail brands, such as within the automotive and financial industries, that wish to reach the engaged shopper within this channel. Word of Mouth Advertisements provides brands with the ability to increase engagement with their advertising through the inclusion of authentic consumer sentiment. Mobile Advertising enables brands to reach consumers on their mobile devices.
The Company competes with Pluck, Reevoo, Gigya, Viewpoints, Google and Facebook.
Advisors' Opinion:- [By Rick Munarriz]
Bazaarvoice (NASDAQ: BV ) was another big winner, soaring 27% higher on the week after posting better-than-expected financial results. Bazaarvoice's adjusted net loss of $0.12 a share was slightly better than the $0.13 a share in red ink that the pros were projecting.
- [By Jake L'Ecuyer]
Bazaarvoice (NASDAQ: BV) tumbled 15.09 percent to $7.01 as the U.S. District Court in the Northern District of California ruled against the company's acquisition of PowerReviews.
- [By Eddie Staley]
Bazaarvoice (NASDAQ: BV) tumbled 11.52 percent to $7.30 as the US District Court in the Northern District of California ruled against the company's acquisition of PowerReviews. Sears Holdings (NASDAQ: SHLD) was down, falling 13.88 percent to $36.66 after the company reported a 7.4% drop in same-store sales at Kmart and Sears for the nine-week period ended January 6. The department store expected to post a loss for the fourth quarter and full year.
- [By Roberto Pedone]
Another earnings short-squeeze prospect is Bazaarvoice (BV), a provider of social commerce software solutions, which is set to release numbers on Wednesday after the market close. Wall Street analysts, on average, expect Bazaarvoice to report revenue of $44.12 million on a loss of 8 cents per share.
The current short interest as a percentage of the float for Bazaarvoice is very high at 14.4%. That means that out of the 41.18 million shares in the tradable float, 6.33 million shares are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 11.6%, or by 656,000 shares. If the bears are caught pressing their bets into a bullish quarter, then shares of BV could rip sharply higher post-earnings as the shorts rush to cover some of their bets.
From a technical perspective, BV is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been trending sideways inside of a consolidation pattern for the last month and change, with shares moving between $10.15 on the downside and $11.50 on the upside. Any high-volume move above the upper-end of its recent range post-earnings could trigger a major breakout trade for shares of BV.
If you're bullish on BV, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $11.35 to $11.50 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 661,797 shares. If that breakout triggers, then BV will set up to re-test or possibly take out its next major overhead resistance levels at $13 to $14 a share.
I would simply avoid BV or look for short-biased trades if after earnings it fails to trigger that breakout and then drops back below its 50-day at $10.34 a share and then below some key near-term support at $10.15 a share with high volume. If we get that m
Hot Tech Companies For 2014: Regulus Therapeutics Inc (RGLS)
Regulus Therapeutics Inc., incorporated on September 5, 2007, is a biopharmaceutical company focused on discovering and developing microRNAs to treat a range of diseases. microRNAs are naturally occurring ribonucleic acid (RNA), molecules that play a critical role in regulating key biological pathways. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs. As of December 31, 2012, the Company�� operations included acquiring and in-licensing intellectual property rights, developing its microRNA, undertaking basic research around microRNA targets and conducting preclinical studies for its initial programs.
The Company is developing RG-101 for the treatment of HCV and is advancing other microRNA therapeutics toward clinical development in several areas, including oncology, fibrosis and metabolic diseases. The Company intends to focus its resources on product opportunities in therapeutic areas where development and commercialization activities are appropriate for its size and financial resources, which the Company anticipates will include niche indications and orphan diseases.
The Company competes with Groove Biopharma, Inc., miRagen Therapeutics, Inc., Mirna Therapeutics, Inc., and Santaris Pharma A/S.
Advisors' Opinion:- [By Sean Williams]
Regulus Therapeutics (NASDAQ: RGLS )
Since presenting at the Deutsche Bank Healthcare Conference two weeks ago, shares of Regulus Therapeutics have been absolutely on fire. A mixture of ASCO and IPO fever have revived the love for newer issues, and having big name pharmaceutical companies gobbling up a majority of its IPO'd shares certainly helps its cause. - [By Brian Orelli]
Partners like this investment idea
When Regulus Therapeutics (NASDAQ: RGLS ) went public last year, investors weren't the only ones buying the share offering; Regulus' partners and founders clearly thought it was a good investment idea, because they bought more shares. Lots of them. AstraZeneca, Biogen Idec, Sanofi, GlaxoSmithKline�and Isis combined to purchase more than 70% of the shares that raised nearly $81 million for the biotech. - [By Sean Williams]
A blast to the past
It's occasionally very difficult to value biotech stocks, because of the wide range of outcomes possible given their pipelines. Other times, as in the case with Regulus Pharmaceuticals (NASDAQ: RGLS ) , I bang my head against a table and wonder what the heck investors are thinking.
No comments:
Post a Comment